ConductScience.org, home

Paper3263232

Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.

Wilson R and 6 others. Clin Exp Immunol, 1988. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide. Papers, record 3263232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3263232

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1988
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2018-11-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilson RR
2McKillop JHJ H
3Pearson CC
4Burnett AKA K
5Gunn II
6McNicol AMA M
7Thomson JAJ A

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AutoantibodiesMajor topic
Graves DiseaseMajor topic
Receptors, ThyrotropinMajor topic
T-LymphocytesMajor topic
Thyroid GlandMajor topic
Carbimazole
Drug Therapy, Combination
Humans
Potassium Iodide
Premedication

Source PubMed

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
147,482Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs.Lancet1975https://conductscience.org/library/papers/47482PubMed
2946,342Rapid simultaneous radioimmunoassay for the measurement of triiodothyronine and thyroxine in unextracted human serum.Acta Endocrinol (Copenh)1976https://conductscience.org/library/papers/946342PubMed
3416,927Evidence for thyroidal secretion of 3,3',5'-triiodothyronine in man and its control by TSH.Clin Endocrinol (Oxf)1978https://conductscience.org/library/papers/416927PubMed
4581,471The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis.Br J Obstet Gynaecol1978https://conductscience.org/library/papers/581471PubMed
56,276,967Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes.Scand J Immunol1981https://conductscience.org/library/papers/6276967PubMed
62,959,679Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease.J Clin Endocrinol Metab1987https://conductscience.org/library/papers/2959679PubMed
76,142,350Evidence that thyroid-stimulating antibody is produced in the thyroid gland.Lancet1984https://conductscience.org/library/papers/6142350PubMed
86,325,045Direct and quantitative measurement by immunoprecipitation assay of anti-thyrotrophin receptor antibodies in sera of patients with Graves' disease.Clin Endocrinol (Oxf)1984https://conductscience.org/library/papers/6325045PubMed
92,863,338Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels.J Nucl Med1985https://conductscience.org/library/papers/2863338PubMed
102,875,587Thyroid glands in patients with Graves' disease are sources of thyrotropin-binding inhibitory (TBI) activity.Acta Endocrinol (Copenh)1986https://conductscience.org/library/papers/2875587PubMed
112,953,751Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.J Clin Endocrinol Metab1987https://conductscience.org/library/papers/2953751PubMed
126,291,808An improved radioreceptor assay for TSH receptor antibodies.Clin Endocrinol (Oxf)1982https://conductscience.org/library/papers/6291808PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn Papers
7,911,812The presence of higher levels of thyroglobulin, but not thyroid autoantibodies, in the thyroid vein in Graves' disease.J Endocrinol Invest1994https://conductscience.org/library/papers/7911812

Source PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TSHR7,253PubTator's text mininghttps://conductscience.org/library/genes/7253

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3263232

GET https://conductscience.org/api/papers/v1/3263232/authors